Novartis Restructuring Continues as Pharmaceuticals Division Splits, Along With Pharma CEO, an Industrial Info News Alert

SUGAR LAND, TX--(Marketwired - May 27, 2016) - Reported by Annette Kreuger, Industrial Info Resources, Incorporated (Sugar Land, Texas) -- One of the Pharmaceutical-Biotech Industry's top three drug makers, Swiss-based Novartis International AG (NYSE:NVS) (Basel, has restructured its pharmaceuticals division by creating two business units -- Novartis Pharmaceuticals and Novartis Oncology. Coinciding with the organizational split, the division head and chief executive officer of the company's Pharmaceuticals division, David Epstein, called it quits.

For details, view the entire article by subscribing to Industrial Info's Premium Industry News, or browse other breaking industrial news stories at www.industrialinfo.com.

Industrial Info Resources (IIR), with global headquarters in Sugar Land, Texas, five offices in North America and 10 international offices, is the leading provider of global market intelligence specializing in the industrial process, heavy manufacturing and energy markets. Industrial Info's quality-assurance philosophy, the Living Forward Reporting Principle™, provides up-to-the-minute intelligence on what's happening now, while constantly keeping track of future opportunities. To contact an office in your area, visit the www.industrialinfo.com "Contact Us" page.

Contact:
Brian Ford
[phone]